Drug Shortage Report for PROCAINAMIDE HYDROCHLORIDE INJECTION USP
Report ID | 135226 |
Drug Identification Number | 02184486 |
Brand name | PROCAINAMIDE HYDROCHLORIDE INJ. USP |
Common or Proper name | PROCAINAMIDE HYDROCHLORIDE INJ. USP |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PROCAINAMIDE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 ML 10 LIVI CA |
ATC code | C01BA |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-03-05 |
Estimated end date | 2021-03-26 |
Actual end date | 2021-03-26 |
Shortage status | Resolved |
Updated date | 2021-03-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-03-29 | French | Compare |
v5 | 2021-03-29 | English | Compare |
v4 | 2021-03-15 | French | Compare |
v3 | 2021-03-15 | English | Compare |
v2 | 2021-03-08 | French | Compare |
v1 | 2021-03-08 | English | Compare |
Showing 1 to 6 of 6